Worldwide Pharmaceuticals to 2021: Drifting Towards Big Data & Analytics - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jan 11, 2019--The “Pharmaceuticals: Drifting towards Big Data & Analytics - Drivers, challenges and technology developments” report has been added to ResearchAndMarkets.com’s offering.
Pharmaceuticals: Drifting towards Big Data & Analytics is an attempt to analyze the key trends expected to impact the Pharmaceuticals industry and its various stakeholders in 2018.
Although the adoption of big data in pharmaceutical operations has been focused mostly on R&D, vendors are exploring its potential use in other operational processes. In supply chain, it helps pharmaceutical companies diagnose issues in their logistics, supplier performance, procurement, delays in delivery, demand management, etc. Vendors are launching BDA solutions that focus on increasing supply chain productivity of pharmaceutical companies.
With competition increasing in the pharmaceutical sector and the market flooded with a multitude of treatments and therapies, determining drug efficacy and designing market strategies remains a priority, while maintaining drug safety. The use of big data in these operational domains will enable pharmaceutical companies to introduce innovations in both products and processes. With digital transformation being the main priority of most pharmaceutical enterprises, the adoption of BDA and AI platforms are expected to increase in the coming years.
ScopeOverview of the technology and its relevance in the verticals. Key challenges faced by the industry verticals (pharmaceutical) pertinent to its technology (big data & analytics) implementation. Elaborate overview of supply side and demand side trends affecting the technology growth. Overview of the revenue opportunities in the big data & analytics market for the pharmaceutical sector through to 2021 - highlighting the market size and growth by technology, geography, sectors, and size band. Moreover, the report also outlines enterprises’ investment priorities in the big data & analytics segment for the pharmaceutical sector. Future recommendation and market opportunities for big data & analytics segment in the pharmaceutical industry.
Reasons to BuyHelps the reader to understand the big data & analytics market landscape in the pharmaceutical industry, the recent trends, and challenges. The most exhaustive and up-to-date report providing revenue opportunity forecasts in the big data & analytics market from 2016 to 2021, spanning four technology segments, six regions, and two size bands. Extensive technology growth predictions based on adoption indicators, end-user technology demand, ICT survey results, and macroeconomic factors. The report provides a detailed breakdown of the opportunities within the big data & analytics segment and its sub categories.
2 Challenges Impacting Pharmaceuticals in Big Data Analytics
3 Market Dynamics
4 BI Investment Priorities in the Pharmaceutical Sector
5 Market Size and Forecast
7 Future Outlook
For more information about this report visit https://www.researchandmarkets.com/research/bc5jqg/worldwide?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190111005374/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Big Data,Data Analytics
INDUSTRY KEYWORD: TECHNOLOGY DATA MANAGEMENT HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 01/11/2019 12:14 PM/DISC: 01/11/2019 12:14 PM